{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-000286","form_type":"8-K","ticker":"CABR","cik":"0002020737","company_name":"Caring Brands, Inc.","filed_at":"2026-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.008191+00:00","generated_at":"2026-05-16T11:44:32.801829+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Caring Brands enters exclusive global license for Emesyl nausea relief product","bullets":["Licensed Emesyl OTC nausea product from Itonis; exclusive worldwide rights to manufacture, market, distribute.","8% royalty on net sales; potential to earn 7% of Itonis equity per $200k in sales.","License may terminate if sales ≤$25k for four consecutive quarters after launch.","Global nausea treatment market projected >$6.23B in 2025, per QY Research.","CEO notes expansion of health/wellness portfolio; further updates expected on timelines."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-000286","json":"https://secwatch.observer/filing/0001493152-26-000286.json","markdown":"https://secwatch.observer/filing/0001493152-26-000286.md","text":"https://secwatch.observer/filing/0001493152-26-000286.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2020737/000149315226000286/0001493152-26-000286-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2020737/000149315226000286/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:44:32.801829+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4076b63caa7514ffc9c774cb2963544b4e721823","claim":"Caring Brands, Inc. entered into License Agreement with Itonis Pharmaceuticals (effective 2025-12-31).","evidence_excerpt":"On December 31, 2025, Caring Brands, Inc., a Nevada corporation, (the “ Company ”), entered into a license agreement (the “ License Agreement ”) with Itonis Pharmaceuticals (“ Itonis ”), a Nevada corporation.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2020737/000149315226000286/0001493152-26-000286-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"license"},{"label":"Counterparty","value":"Itonis Pharmaceuticals"},{"label":"Effective","value":"2025-12-31"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}